A carregar...
Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia
Anti-CD20 antibody therapy has been a useful medication for managing non-Hodgkin's lymphoma as well as autoimmune diseases characterized by autoantibody generation. CD20 is expressed during most developmental stages of B lymphocytes; thus, CD20 depletion leads to B-lymphocyte deficiency. As the...
Na minha lista:
| Publicado no: | Infect Immun |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4399075/ https://ncbi.nlm.nih.gov/pubmed/25733518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.03099-14 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|